Ketamine can reduce suicidal thoughts in depressed patients within hours of administration, a new study from Columbia Psychiatry has found.
An innovative NIMH-funded research study on personalizing depression treatment is under way at Columbia and the New York State Psychiatric Institute, as well as three other sites nationwide.
Psychiatrist Mark Olfson suggests suicide prevention efforts should be focused on specific periods of high risk.
Physicians may be less likely to intensify blood pressure treatment in patients with uncontrolled hypertension who are also depressed.
Study finds vitamin D has little to no effect on depression.
A significant number of mental health professionals would be unwilling to live near or work with someone who has an untreated psychiatric disorder, especially schizophrenia.